Personalized medicine with biologics for severe type 2 asthma: current status and future prospects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized medicine with biologics for severe type 2 asthma: current status and future prospects

Published:2017-11-14 Issue:1 Volume:10 Page:34-45
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Godar Marie¹²³^ORCID,Blanchetot Christophe¹,de Haard Hans¹,Lambrecht Bart N.²³⁴⁵^ORCID,Brusselle Guy⁶⁵^ORCID

Affiliation:

1. argenx BVBA, Zwijnaarde, Belgium

2. VIB-UGent Center for Inflammation Research, Ghent, Belgium

3. Department of Internal Medicine, Ghent University, Ghent, Belgium

4. Department of Pulmonary Medicine, ErasmusMC, Rotterdam, The Netherlands

5. Department of Epidemiology and Respiratory Medicine, ErasmusMC, Rotterdam, The Netherlands

6. Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2017.1392425

Reference73 articles.

1. A summary of the new GINA strategy: a roadmap to asthma control

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

3. Emerging molecular phenotypes of asthma

4. The immunology of asthma

5. Biosimilar drugs: Current status

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choosing the right biologic treatment for individual patients with severe asthma – Lessons learnt from Picasso;Respiratory Medicine;2024-11

2. Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysis;World Allergy Organization Journal;2024-08

3. Geographic and economic influences on benralizumab prescribing for severe asthma in Japan;Scientific Reports;2024-07-02

4. Vaccines for allergy;Metabolomics for Personalized Vaccinology;2024

5. Asthma Phenotypes in the Era of Personalized Medicine;Journal of Clinical Medicine;2023-09-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3